Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2025-12-25 @ 10:55 PM
NCT ID: NCT02249767
Description: Treatment related irritation
Frequency Threshold: 0
Time Frame: 12 weeks
Study: NCT02249767
Study Brief: Bioequivalence Study of Tretinoin Gel 0.05% to Brand Tretinoin Gel
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Brand Tretinoin Treatment of Acne once daily over 12 weeks Tretinoin: Treatment of acne once daily in evening 0 None 0 229 46 229 View
Placebo Vehicle Treatment of acne once daily over 12 weeks Tretinoin: Treatment of acne once daily in evening 0 None 0 115 26 115 View
Generic Tretinoin Treatment of acne once daily over 12 weeks Tretinoin: Treatment of acne once daily in evening 0 None 0 230 49 230 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Irritation from Drug SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View